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point, ED is further defined as mild (22 to 25), mild-to-
moderate (17 to 21), moderate (11 to 16), and severe (10)
(3). In the Kaiser et al. (1) study, “normal” subjects had a
mean (SD) score of the IIEF erectile function domain of
21.3 5.3. Assuming a normal distribution, this means that
almost 80% of normal subjects were below the cut-off for
ED, of whom 40% likely had an IIEF score 20 (mild-to-
moderate ED) and 10% 15 (moderate ED). Thus, many
“normal” subjects were actually impotent, although to a
lesser degree than the true ED group. However, penile color
Doppler sonography (the only test that might have further
differentiated the two groups) was not performed in normal
subjects, and this makes any comment conjectural.
If this observation holds true, differences in the vascular
response between groups should be reconsidered. In fact, if the
dilation response of “normal” patients with ED is combined
with dilation response of the real ED group, one would expect
to obtain a higher mean value of percent vascular dilation. For
example, percent dilation at 60 s after cuff release was 2.4 0.5
versus 3.7  0.5 in the ED and normal group, respectively. If
combined, a mean value of 3% would reasonably become
evident. This result, to still be significantly lower, would
require normals to show an even higher dilation response,
about 4% to 4.5%. This figure seems to be a rather unusual
response after wrist occlusion (4).
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REPLY
Dr. Montorsi and colleagues express concerns over the
International Index of Erectile Function (IIEF)-15 data
presented in our study (1). We inadvertently stated that the
data presented were the erectile dysfunction (ED) domain
of the IIEF-15, but in fact the data cited in our report were
an average of each individual domain of the IIEF-15. In
response to their letter to the editor we went back to the raw
data and calculated both the ED domain of the IIEF-15
and the IIEF-5 (an abbreviated version of the IIEF-15).
These results are presented below.
The IIEF-15 domain consists of six questions (1, 2, 3, 4,
5, and 15) with a maximum score of 30 and a cut-off of25
for ED (2). The ED group in our study had an IIEF-15 ED
domain score of 16.1 versus 26.8 for the normal group (p 
0.000001).
The IIEF-5 is a validated brief version of the longer
questionnaire (questions 2, 4, 5, 7, and 15 of the IIEF-15)
(3,4). These five questions have been found to discriminate
most highly between men with and without ED. The
maximum score for the IIEF-5 is 25, with a cut-off of 21
for ED. The ED group in our study had an IIEF-5 of 12.9
versus 22.3 for the normal group (p  0.000001).
We appreciate the opportunity to clarify this issue. Based
on the results listed above for the ED domain of the
IIEF-15 and the IIEF-5, our patients had significant
symptoms of ED and our control subjects did not have ED.
Therefore, the significance of our original observations is
valid, and no further reassessments of the data are war-
ranted.
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Exercise Release of Cardiac Natriuretic
Peptides Is Markedly Enhanced When
Patients With Coronary Artery Disease
Are Treated Medically by Beta-Blockers
We read with interest the recent study by Marie et al. (1),
which concluded that patients with chronic coronary artery
disease exhibited much higher exercise release of (ANP) and
brain natriuretic peptide (BNP) when they were treated
with beta-blockers. Exercise-related increase in natriuretic
peptides had been reported across a majority of patients
undergoing exercise treadmill test for evaluation of ischemic
heart disease (2–5). The investigators postulated that the
mechanisms of enhanced natriuretic peptide release second-
ary to beta-blockade may be related to exercise-induced
increase in wall tension and cavity size. However, the
researchers did not report the presence of reversible isch-
emia among the patients who were receiving beta-blocker
therapy.
We recently reported (6) that exercise-induced increase in
B-type natriuretic peptide was more prominent in patients
with evidence of reversible ischemia on single-photon emis-
sion computed tomography (SPECT). It is therefore pos-
sible that the presence of exercise-induced reversible isch-
emia may serve as a confounding factor in this patient
population, and we wonder whether the BNP rise among
patients receiving beta-blockers during exercise is significant
if the data are adjusted for presence of reversible ischemia.
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REPLY
When we started our study, we hoped that an enhanced
secretion of atrial natriuretic peptide (ANP) and/or brain
natriuretic peptide (BNP) might allow for detecting exercise
ischemia. However, as it was already pointed out in our
report, myocardial ischemia was documented by exercise-
single-photon emission computed tomography (SPECT) in
63 of our 104 patients with coronary artery disease, and this
ischemia was not a predictor of the exercise increase in
blood levels of either ANP or BNP (1). More precisely, in
the 63 patients with SPECT-ischemia, the difference be-
tween exercise and rest concentrations of BNP was, on
average, 14  20 ng/l. Equivalent values were observed in
patients with normal SPECT: 14  35 ng/l. By contrast,
much higher values were observed in the remaining patients
showing SPECT-necrosis: 49  55 ng/l (p  0.001).
As it was already discussed in our study (1), this is mainly
an acute release of peptides from secretory granules that is
likely to allow a prompt exercise rise in the blood concen-
trations of peptides. Therefore, this rise depends on 1) the
amount of peptides, which may be previously stored within
secretory granules, and 2) the mechanism of peptides release
from these granules.
Granule storage is known to rise in parallel to the resting
blood concentrations of natriuretic peptides and to the level
of left ventricular dysfunction. This is presumably the reason
why we found that the rest concentration of peptides was a
main predictor of the exercise increase in peptide concen-
tration. For both ANP and BNP, however, rest concentra-
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